buyModerate cluster of 2
Raj Mehra bought $100k of SEEL
See Remarks at SEELOS THERAPEUTICS, INC.. 75,757 shares at an average of $1.32, traded Dec 1, 2023, filed Dec 1, 2023.
Conviction score
43Value
$100k
75,757 shares
Holdings after
185,142
+69% from before
From 52-week low
-
no price yet
From 52-week high
-
no price yet
Score components
- +15RoleOfficer
- +10Trade size$100k at market
- +10Relative to holdingsHoldings up 69%
- 0Price contextNo price history yet
- +8Cluster2 insiders buying within 14 days
- 0Repeat buyingFirst buy in 90 days
- 0Track recordToo few past buys to judge (0 with prices)
What happened after comparable buys
Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.
Rows in this filing
Every transaction in Form 4 0001104659-23-122840, as filed. Open on EDGAR
| Date | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|
| Dec 1, 2023 | POpen-market purchase Common Stock | +75,757 | $1.32 | $100k | 185,142 | Dec 1, 2023 |
| Dec 1, 2023 | POpen-market purchase Common Stock Warrant (right to buy)derivative | +75,757 | - | - | 75,757 | Dec 1, 2023 |
Related signals
Other insiders at SEELOS THERAPEUTICS, INC. and this insider’s other filings.
| Score | Company | Insider | Value | Holdings | Filed |
|---|---|---|---|---|---|
| 50Moderate | SEELOS THERAPEUTICS, INC. | Michael Joseph Golembiewski Chief Financial Officer | $100k 83,000 shares | +2406% |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.